Active	Status	Sponsor type	Region	Phase	Filter
3 Active 6 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Illerhaus, Gerald
MTR², NCT05583071: Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients with PCNSL	Recruiting	2	20	Europe	Tafasitamab, Lenalidomide, Rituximab, Methotrexate	University of Cologne, Incyte Corporation	Non-Hodgkin Lymphoma	02/27	04/27